LIN jingxian – Trademark Portfolio

Entity Type: 01

LIN jingxian owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as DACLL, HANZIMO, and CBLIORUD. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 16 (Paper Goods). Headquartered in Shenzhen, Guangdong.

Chenhangtaoyuan 1D 2201,

Wulian youyilu,Longgang

Shenzhen, Guangdong 518000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CBLIORUD
CBLIORUD
Registered 2022
HANZIMO
HANZIMO
Registered 2022
DACLL
DACLL
Registered 2019

Trademark Classifications

LIN jingxian's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does LIN jingxian have?

LIN jingxian has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does LIN jingxian file in?

LIN jingxian files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods). Class 25 covers clothing, footwear, headgear.

What are LIN jingxian's most well-known trademarks?

LIN jingxian's registered trademark portfolio includes well-known marks such as DACLL, HANZIMO, and CBLIORUD. These are among 3 currently registered trademarks in the portfolio.

What is LIN jingxian's trademark registration success rate?

LIN jingxian has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.